Position in HRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$84,080
-$63,559 QoQ
Shares Held
195,537
+6.0% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. HRTX ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,080 | 195,537 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $147,639 | 184,549 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $264,314 | 203,319 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $283,062 | 224,653 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $460,446 | 222,438 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $378,606 | 172,094 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $271,851 | 177,681 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $349,814 | 175,786 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $645,652 | 184,472 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $388,470 | 140,242 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $230,854 | 135,797 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $139,258 | 135,202 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $159,404 | 137,418 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $206,031 | 136,445 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $332,217 | 132,887 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $545,472 | 129,259 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $336,995 | 120,787 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $579,344 | 101,284 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $941,284 | 103,098 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,122,866 | 105,039 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,564,866 | 100,829 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,700,039 | 104,876 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,435,354 | 115,038 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,702,254 | 114,862 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,983,290 | 134,826 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,381,985 | 117,716 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||